Stock HALO HALOZYME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Halozyme Therapeutics, Inc.

Equities

HALO

US40637H1095

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
39.91 USD +0.23% Intraday chart for Halozyme Therapeutics, Inc. +3.47% +7.98%
Apr. 25 Halozyme Therapeutics, Inc. Announces the Election of Mahesh Krishnan, M.D. to its Board of Directors CI
Apr. 18 Halozyme Therapeutics Insider Sold Shares Worth $768,390, According to a Recent SEC Filing MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. HALO Stock
  4. Revisions Halozyme Therapeutics, Inc.